Literature DB >> 17601878

Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans.

Diane C McFadden1, Bettina C Fries, Fang Wang, Arturo Casadevall.   

Abstract

Cryptococcus neoformans is a human pathogenic fungus with a capsule composed primarily of glucuronoxylomannan (GXM) that is important for virulence. Current views of GXM structure postulate a polymer composed of repeating mannose trisaccharide motifs bearing a single beta(1,2) glucuronic acid with variable xylose and O-acetyl substitutions to form six triads. GXM from different strains is notoriously variable in triad composition, but it is not known if the polymer consists of one or more motif-repeating units. We investigated the polymeric organization of GXM by using mass spectrometry to determine if its compositional motif arrangement was similar to that of bacterial capsular polysaccharides, namely, a polymer of a single repeating unit. The results were consistent with, and confirmatory for, the current view that the basic unit of GXM is a repeating mannose trisaccharide motif, but we also found evidence for the copolymerization of different GXM repeating units in one polysaccharide molecule. Analysis of GXM from isogenic phenotypic switch variants suggested structural differences caused by glucuronic acid positional effects, which implied flexibility in the synthetic pathway. Our results suggest that cryptococcal capsule synthesis is fundamentally different from that observed in prokaryotes and employs a unique eukaryotic approach, which theoretically could synthesize an infinite number of structural combinations. The biological significance of this capsule construction scheme is that it is likely to confer a powerful avoidance strategy for interactions with the immune system and phagocytic environmental predators. Consistent with this premise, the antigenic variation of a capsular epitope recognized by a nonprotective antibody was observed under different growth conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601878      PMCID: PMC1951120          DOI: 10.1128/EC.00162-07

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  28 in total

1.  Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum.

Authors:  Diane C McFadden; Oscar Zaragoza; Arturo Casadevall
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Molecular architecture of the Cryptococcus neoformans capsule.

Authors:  Marcellene A Gates; Peter Thorkildson; Thomas R Kozel
Journal:  Mol Microbiol       Date:  2004-04       Impact factor: 3.501

Review 3.  Role of phagocytosis in the virulence of Cryptococcus neoformans.

Authors:  Maurizio Del Poeta
Journal:  Eukaryot Cell       Date:  2004-10

4.  Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection.

Authors:  A Casadevall; J Mukherjee; S J Devi; R Schneerson; J B Robbins; M D Scharff
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

5.  Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans.

Authors:  R A Bryan; O Zaragoza; T Zhang; G Ortiz; A Casadevall; E Dadachova
Journal:  Eukaryot Cell       Date:  2005-02

6.  Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.

Authors:  R Cherniak; H Valafar; L C Morris; F Valafar
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

7.  Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan.

Authors:  Javier García-Rivera; Yun C Chang; K J Kwon-Chung; Arturo Casadevall
Journal:  Eukaryot Cell       Date:  2004-04

Review 8.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

Review 9.  Cryptococcus neoformans capsule biosynthesis and regulation.

Authors:  Guilhem Janbon
Journal:  FEMS Yeast Res       Date:  2004-09       Impact factor: 2.796

10.  Antibodies produced in response to Cryptococcus neoformans pulmonary infection in mice have characteristics of nonprotective antibodies.

Authors:  Oscar Zaragoza; Arturo Casadevall
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more
  53 in total

1.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

2.  Regulation of Cryptococcus neoformans capsule size is mediated at the polymer level.

Authors:  Aki Yoneda; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2007-12-21

3.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

4.  Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation.

Authors:  A Guerrero; N Jain; X Wang; B C Fries
Journal:  Infect Immun       Date:  2010-01-04       Impact factor: 3.441

Review 5.  Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis.

Authors:  Gunjan Gupta; Bettina C Fries
Journal:  Future Microbiol       Date:  2010-05       Impact factor: 3.165

6.  A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.

Authors:  Mark Probert; Xin Zhou; Margaret Goodall; Simon A Johnston; Ewa Bielska; Elizabeth R Ballou; Robin C May
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

7.  Pbx proteins in Cryptococcus neoformans cell wall remodeling and capsule assembly.

Authors:  Pardeep Kumar; Christian Heiss; Felipe H Santiago-Tirado; Ian Black; Parastoo Azadi; Tamara L Doering
Journal:  Eukaryot Cell       Date:  2014-02-28

8.  Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans.

Authors:  Tiffany Guess; Hoyin Lai; Serenah E Smith; Linda Sircy; Kirsten Cunningham; David E Nelson; Erin E McClelland
Journal:  J Vis Exp       Date:  2018-02-27       Impact factor: 1.355

Review 9.  Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii.

Authors:  Neena Jain; Bettina C Fries
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

10.  Characterization of phenotypic switching in Cryptococcus neoformans biofilms.

Authors:  Luis R Martinez; David C Ibom; Arturo Casadevall; Bettina C Fries
Journal:  Mycopathologia       Date:  2008-06-21       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.